We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $416B
1-Year Est. Return 33.63%
 

Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.

This Fund
S&P 500
This Quarter Est. Return
+13.33%
1 Year Est. Return
+33.63%
3 Year Est. Return
+104.86%
5 Year Est. Return
+133.18%
10 Year Est. Return
+557.96%
AUM
$273B
AUM Growth
+$112B
Cap. Flow
+$85.1B
Cap. Flow %
31.22%
Top 10 Hldgs %
26.87%
Holding
5,469
New
898
Increased
2,915
Reduced
940
Closed
253

Sector Composition

Rank Sector Weight
1 Technology 20.95%
2 Financials 8.18%
3 Consumer Discretionary 7.81%
4 Healthcare 7.12%
5 Communication Services 6.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OBDC icon
4426
Blue Owl Capital
OBDC
$5.58B
$132K ﹤0.01%
8,971
-33,937
-79% -$482K
TRAK icon
4427
ReposiTrak
TRAK
$158M
$131K ﹤0.01%
13,040
+10,123
+347% +$99.3K
PRLD icon
4428
Prelude Therapeutics
PRLD
$373M
$130K ﹤0.01%
30,526
+17,210
+129% +$52.4K
GIS icon
4429
CALL
General Mills
GIS
$19.3B
$130K ﹤0.01%
+2,000
New +$129K
THRX
4430
DELISTED
Theseus Pharmaceuticals, Inc. Common Stock
THRX
$130K ﹤0.01%
32,097
+24,265
+310% +$74K
KLG
4431
PUT
DELISTED
WK Kellogg Co
KLG
$130K ﹤0.01%
+9,875
New +$111K
LGO
4432
Largo
LGO
$67.7M
$130K ﹤0.01%
56,080
DADA
4433
DELISTED
Dada Nexus
DADA
$129K ﹤0.01%
38,921
LBPH
4434
DELISTED
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
$129K ﹤0.01%
21,421
+18,634
+669% +$92.9K
EEX
4435
DELISTED
Emerald Holding
EEX
$129K ﹤0.01%
21,581
+18,591
+622% +$97.7K
VBK icon
4436
Vanguard Morningstar Small-Cap Growth ETF
VBK
$23.9B
$128K ﹤0.01%
530
PAYS icon
4437
Paysign
PAYS
$693M
$128K ﹤0.01%
45,708
+39,724
+664% +$87.2K
CTXR icon
4438
Citius Pharmaceuticals
CTXR
$17.6M
$128K ﹤0.01%
6,753
+5,882
+675% +$112K
CION icon
4439
CION Investment
CION
$362M
$127K ﹤0.01%
+11,267
New +$120K
DCBO
4440
Docebo
DCBO
$520M
$127K ﹤0.01%
2,632
-397
-13% -$17.7K
AMPX icon
4441
Amprius Technologies
AMPX
$1.58B
$127K ﹤0.01%
23,985
-5,178
-18% -$19.5K
KWY
4442
Kingsway Corp
KWY
$260M
$127K ﹤0.01%
15,082
+12,991
+621% +$98.3K
IEP icon
4443
Icahn Enterprises
IEP
$5.42B
$126K ﹤0.01%
7,349
-8,126
-53% -$142K
GXC icon
4444
State Street SPDR S&P China ETF
GXC
$476M
$126K ﹤0.01%
1,844
AIRS icon
4445
AirSculpt Technologies
AIRS
$337M
$125K ﹤0.01%
16,748
+14,449
+628% +$91.6K
UBOT icon
4446
Direxion Daily Robotics Artificial Intelligence & Automation Index Bull 2X ETF
UBOT
$25.9M
$125K ﹤0.01%
6,088
GOCO
4447
DELISTED
GoHealth
GOCO
$125K ﹤0.01%
9,334
+4,978
+114% +$68.1K
MGK icon
4448
Vanguard Morningstar Mega Cap Growth ETF
MGK
$33.9B
$124K ﹤0.01%
2,385
FONR
4449
DELISTED
Fonar
FONR
$124K ﹤0.01%
+6,328
New +$105K
DNMR
4450
DELISTED
Danimer Scientific, Inc.
DNMR
$123K ﹤0.01%
3,008
+2,632
+700% +$143K

Similar funds

Barclays's Q4 2023 Portfolio in Review

As of Q4 2023, Barclays held 5,469 positions worth $273B, up 70% from $161B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Barclays deployed $85.1B of net new capital in Q4 2023, opening 898 new positions and adding to 2,915 existing holdings. Its largest new stake was AngloGold Ashanti: 9,667,894 shares worth $181M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 27% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was CRH, an estimated $673M trimmed.

  • Barclays's largest Q4 2023 buy was AngloGold Ashanti: 9,667,894 shares worth $181M.
  • Barclays added most to Meta Platforms (Facebook) in Q4 2023, an estimated $1.51B increase.
  • Barclays's biggest Q4 2023 reduction was CRH, cutting an estimated $673M.
  • Barclays fully exited Activision Blizzard in Q4 2023, selling an estimated $417M.
  • Barclays's ten largest holdings make up 27% of its $273B portfolio in Q4 2023.
  • Barclays opened 898 new positions and closed 253 in Q4 2023.
  • Barclays's portfolio value rose 70% quarter-over-quarter to $273B.

Based on Barclays's 13F filing for Q4 2023, filed 15 Feb 2024.